BMP7 and osteoarthritis, knee: The double-blind, randomized, single dose incremental safety study of bone morphogenetic protein (38A BMP-7) in knee OA subjects (NCT01133613) and the dose discovery study of BMP-7 in knee osteoarthritis patients (NCT01111045) are also being further evaluated.